LONGITUDINAL CHANGES OF SERUM-INSULIN CONCENTRATION AND INSULIN ANTIBODY FEATURES IN PERSISTENT INSULIN AUTOIMMUNE SYNDROME (HIRATAS DISEASE)

被引：37

作者：

EGUCHI, Y

UCHIGATA, Y

YAO, KS

YOKOYAMA, H

HIRATA, Y

OMORI, Y

机构：

[1] Diabetes Center, Tokyo Women's Medical College

来源：

AUTOIMMUNITY | 1994年 / 19卷 / 04期

关键词：

INSULIN ANTIBODY; SCATCHARD ANALYSIS; HYPOGLYCEMIC ATTACK;

D O I：

10.3109/08916939409071354

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In a 56-year-old woman with granulomas of gold thioglucose in her hips, who developed insulin autoimmune syndrome, the relationships among the frequency or severity of hypoglycemic attacks, serum insulin (IRI) concentration, and characteristics of insulin antibodies were investigated during the clinical course with steroid treatment and two resection operations for the gold-thioglucose granulomas. When hypoglycemia was severe, the total IRI level was elevated, and Scatchard analysis showed that a high-affinity (kl), low-capacity (bl) population of antibodies had a relatively low affinity constant and very high binding capacity compared with the same population of antibodies in insulin-treated diabetic patients. When the attacks were relieved by steroid treatment and/or granuloma resection operation, the total IRI level was decreased and the high-affinity (kl), low-capacity (bl) population of antibodies showed a higher affinity constant and a lower binding capacity than those during the attacks. This indicated that the antibodies changed their characteristics to release insulin into the serum. The kl/bl population of insulin antibodies with the lower affinity constant and higher binding capacity may easily release human insulin into the serum, leading to hypoglycemia. The longitudinal change of the kl/bl population suggests a clonal change of the B cells producing the insulin antibody in insulin autoimmune syndrome.

引用

页码：279 / 284

页数：6

共 16 条

[11] Masuda A., Tsushima T., Shizume K., Shibata K., Kinoshita A., Omura M., Sato Y., Demura H., Ohashi H., Odagiri R., Hirata Y., Insulin autoimmune syndrome with insulin-resistant diabetes at the incipient stage prior to hypoglycemic attacks, J. Endocrinol. Invest, 9, pp. 507-512, (1986)
[12] Lee Y.-J., Shin S.-J., Torng J.-K., Liu W.-J., Tsai J.-H., Insulin autoimmune syndrome in a methimazole-treated Graves' patient with polyclonal anti-insulin autoantibodies: Report of a case, J. Formosa Med. Assoc, 86, pp. 164-170, (1987)
[13] Cho B.Y., Lee H.K., Koh C.-S., Min H.K., Spontaneous hypoglycemia and insulin autoantibodies in a patient with Graves' disease, Diabetes Res. Clin. Prac, 3, pp. 119-124, (1987)
[14] Uchigata Y., Kuwata S., Tsushima T., Tokunaga K., Miyamoto M., Tsuchikawa K., Hirata Y., Juji T., Omori Y., Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata Disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1 *0406, J. Clin. Endocrinol. Metab, 77, pp. 249-251, (1993)
[15] Ito Y., Nieda M., Uchigata Y., Nishimura M., Tokunaga K., Kuwata S., Obata F., Tadokoro K., Hirata Y., Omori Y., Juji T., Recognition of human insulin in the context of HLA-DRB 1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors, J. Immunol, 151, pp. 5770-5776, (1993)
[16] Uchigata Y., Eguchi Y., Hasumi S., Hirata Y., The immunoglobulin class, the subclass and the ratio of k: light chain of autoantibodies to human insulin in insulin autoimmune syndrome, Autoimmunity, 3, pp. 289-297, (1989)

← 1 2 →